Clinical Trial Update: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating aflibercept in combination with FOLFOX6 for previously untreated Stage IV colorectal cancer has completed enrollment and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Mucinous Adenocarcinoma of the Colon
• Mucinous Adenocarcinoma of the Rectum
• Rectal Cancer
• Signet Ring Adenocarcinoma of the Colon
• Signet Ring Adenocarcinoma of the Rectum

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)
• Zaltrap (ramucirumab)

Snippet

Sponsor: John Hays | Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 2 | Status: COMPLETED | Results posted: 2025-02-05